An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for definitions and for misbranding.

This bill amends Pennsylvania's Controlled Substance, Drug, Device and Cosmetic Act to clarify labeling requirements for certain oral medications. It specifically defines "gluten-containing grain" to include wheat, rye, barley, and oats, ensuring that any oral drug containing ingredients derived from these grains must be clearly labeled. The new provision mandates that product labels must state the drug contains a gluten-derived ingredient and identify the specific type of grain used. By updating these definitions and labeling rules, the legislation aims to improve transparency for consumers and healthcare providers regarding potential gluten sources in medicines. The changes will not take effect until two years after the bill is enacted.